Drug–clay nanohybrids as sustained delivery systems

Applied Clay Science

Volumn 130, Issue , 2016, Pages 20-32

  Yang, Jae Hun ^a   Lee, Ji Hee ^a   Ryu, Hyeon Ju ^a   Elzatahry, Ahmed A ^b,c   Alothman, Zeid A ^c   Choy, Jin Ho ^a  

^a Ewha Womans University   (South Korea)

^b Qatar University ^*  (Qatar)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Clay; Controlled and sustained release; Drug delivery carrier; Nanohybrid

Indexed keywords

BIOCOMPATIBILITY; CLAY; DRUG PRODUCTS; GENE THERAPY; HYDROGEN BONDS; MOLECULES; NANOSTRUCTURED MATERIALS;

DRUG DELIVERY CARRIER; HYDROGEN BONDING INTERACTIONS; INTERCALATION REACTION; LAYERED DOUBLE HYDROXIDES; NANO HYBRIDS; SAFETY AND STABILITIES; SUSTAINED RELEASE; THERAPEUTIC APPLICATION;

CONTROLLED DRUG DELIVERY;

CHEMOTHERAPY; CLAY; DRUG; HYBRIDIZATION; HYDROGEN; HYDROXIDE; SAFETY;

EID: 84960157782     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2016.01.021     Document Type: Article

References (110)

1. Aguzzi, C., Cerezo, P., Viseras, C., Caramella, C., Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 36 (2007), 22–36.
2. Aguzzi, C., Capra, P., Bonferoni, C., Cerezo, P., Salcedo, I., Sánchez, R., Caramella, C., Viseras, C., Chitosan–silicate biocomposites to be used in modified drug release of 5-aminosalicylic acid (5-ASA). Appl. Clay Sci. 50 (2010), 106–111.
3. Anirudhan, T.S., Sandeep, S., Synthesis and characterization of a novel pH-controllable composite hydrogel for anticancer drug delivery. New J. Chem. 35 (2011), 2869–2876.
4. Baek, M., Lee, J.A., Choi, S.J., Toxicological effects of a cationic clay, montmorillonite in vitro and in vivo. Mol. Cell Toxicol 8 (2012), 95–101.
5. Baek, M., Choi, S.J., Effect of orally administered glutathione-montmorillonite hybrid systems on tissue distribution. J. Nanomater. 2012 (2012), 1–7.
6. Baek, M., Choy, J.H., Choi, S.J., Montmorillonite intercalated with glutathione for antioxidant delivery: synthesis, characterization, and bioavailability evaluation. Int. J. Pharm. 425 (2012), 29–34.
7. Bergaya, F., Lagaly, G., (eds.) Handbook of Clay Science, second ed., 2013, Elsevier, Amsterdam.
8. Bhavesh, D.K., Ghanshyam, V.J., Haresh, M.M., Hari, C.B., Biopolymer–clay hydrogel composites as drug carrier: host–guest intercalation and in vitro release study of lidocaine hydrochloride. Appl. Clay Sci. 52 (2011), 364–367.
9. Bi, X., Zhang, H., Dou, L., Layered double hydroxide-based nanocarriers for drug delivery. Pharmaceutics 6 (2014), 298–332.
10. Brigatti, M.F., Galán, E., Theng, B.K.G., Chapter 2. Structure and mineralogy of clay minerals. Bergaya, F., Lagaly, G., (eds.) Handbook of Clay Science, second ed. Part A. Fundamentals, 2013, Elsevier, Amsterdam, 21–81.
11. Calabrese, I., Cavallaro, G., Scialabba, C., Licciardi, M., Merli, M., Sciascia, L., Turco Liveri, M.L., Montmorillonite nanodevices for the colon metronidazole delivery. Int. J. Pharm. 457 (2013), 224–236.
12. Campbell, K.T., Craig, D.Q.M., McNally, T., Modification of ibuprofen drug release from poly(ethylene glycol) layered silicate nanocomposites prepared by hot-melt extrusion. J. Appl. Polym. Sci., 131, 2014, 40284.
13. Carretero, M.I., Clay minerals and their beneficial effects upon human health. A review. Appl. Clay Sci. 21 (2002), 155–163.
14. Carretero, M.I., Pozo, M., Clay and non-clay minerals in the pharmaceutical industry. Appl. Clay Sci. 46 (2009), 73–80.
15. Carretero, M.I., Gomes, C.S.F., Tateo, F., Bergaya, F., Lagaly, G., Clays, drugs and human health. Handbook of Clay Science, second ed. Part B: Techniques and Applications, 2013, Elsevier, Amsterdam, 711–764.
16. Cervini-Silva, J., Nieto-Camacho, A., Ramírez-Apan, M.T., Gómez-Vidales, V., Palacios, E., Montoya, A., de Jesús, E.R., Colloids Surf. B: Biointerfaces 129 (2015), 1–6.
17. Chiari, G., Giustetto, R., Ricchiardi, G., Crystal structure refinements of palygorskite and Maya Blue from molecular modelling and powder synchrotron diffraction. Eur. J. Mineral. 15 (2003), 21–33.
18. Chen, Y., Zhou, A., Liu, B., Liang, J., Tramadol hydrochloride/montmorillonite composite: preparation and controlled drug release. Appl. Clay Sci. 49 (2010), 108–112.
19. Choi, G., Kwon, O.J., Oh, Y., Yun, C.O., Choy, J.H., Inorganic nanovehicle targets tumor in an orthotopic breast cancer model. Sci. Rep., 4, 2014, 4430.
20. Choi, S.J., Oh, J.M., Choy, J.H., Human-related application and nanotoxicology of inorganic particles: complementary as pects. J. Mater. Chem. 18:6 (2008), 615–620.
21. Choi, S.J., Oh, J.M., Lee, G.E., Kim, J.E., Choy, J.H., Inorganic metal hydroxide nanoparticles for targeted cellular uptake via clathrin-mediated endocytosis. Chem. Asian. J. 4 (2009), 67–73.
22. Choy, J.H., Intercalative route to heterostructured nanohybrid. J. Phys. Chem. Solids 65 (2004), 373–383.
23. Choy, J.H., Kwak, S.Y., Park, J.S., Jeong, Y.J., Portier, J., Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 121 (1999), 1399–1400.
24. Choy, J.H., Kwak, S.Y., Jeong, Y.J., Park, J.S., Inorganic layered double hydroxide as a non-viral vector. Angew. Chem. Int. Ed. 39 (2000), 4042–4045.
25. Choy, J.H., Park, T., Huh, H.S., A hybrid of free-base amlodipine with a layered silicate and a process for preparing the same. PCT Int. Appl. WO, 2005018679, 2005, A1.
26. Choy, J.H., Park, T., Lee, Y.J., Kim, D.Y., Park, J.K., 2008. A base forming drug-layered silicate hybrid containing basic polymer and its synthesis method. PCT Int. US 0119519 A.
27. Choy, J.H., Choi, S., Oh, J., Park, T., Clay minerals and layered double hydroxides for novel biological applications. Appl. Clay Sci. 36 (2007), 122–132.
28. Datta, M., Kaur, M., In vitro release of sodium diclofenac from poloxamer 188 modified montmorillonite as an oral drug delivery vehicle. Int. J. Pharm. Pharma. Sci. 6 (2014), 100–110.
29. Dawson, J.I., Oreffo, R.O., Clay: new opportunities for tissue regeneration and biomaterial design. Adv. Mater. 25 (2013), 4069–4086.
30. Depan, D., Kumar, A.P., Singh, R.P., Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater. 5 (2009), 93–100.
31. Galán, E., Properties and applications of palygorskite–sepiolite clays. Clay Miner. 31 (1996), 443–453.
32. Ghadiri, M., Hau, H., Chrzanowski, W., Agus, H., Rohanizadeh, R., Laponite clay as a carrier for in situ delivery of tetracycline. RSC Adv. 3 (2013), 20193–20201.
33. Guggenheim, S, Krekeler, M. P.S., 2011. The structures and microtextures of the palygorskite–sepiolite group minerals. In: Galan E., Singer, A. (Ed.), Developments in Palygorskite-Sepiolite Research; A New Outlook on These Nanomaterials, Elsevier, Amsterdam, 299–324.
34. Hamilton, A.R., Hutcheon, G.A., Roberts, M., Gaskell, E.E., Formulation and antibacterial profiles of clay–ciprofloxacin composites. Appl. Clay Sci. 87 (2014), 129–135.
35. Hitzky, E.R., Aranda, P., Darder, M., Rytwo, G., Hybrid materials based on clays for environmental and biomedical applications. J. Mater. Chem. 20 (2010), 9306–9321.
36. Holešová, S., Valášková, M., Hlaváč, D., Madejová, J., Samlíková, M., Tokarský, J., Pazdziora, E., Antibacterial kaolinite/urea/chlorhexidine nanocomposites: experiment and molecular modelling. Appl. Surf. Sci. 305 (2014), 783–791.
37. IARC, IARC monographs on the evaluation of carcinogenic risks to humans. Silica, Some Silicates, Coal Dust and Para-aramid Fibrils, 68, 1997, 245–282 (Lyon, France).
38. Iliescu, R.I., Andronescu, E., Ghitulica, C.D., Voicu, G., Ficai, A., Hoteteu, M., Montmorillonite–alginate nanocomposite as a drug delivery system – incorporation and in vitro release of irinotecan. Int. J. Pharm. 463 (2014), 184–192.
39. Jain, S., Datta, M., Naturally occurring clay, montmorillonite, as a drug delivery vehicle for in vitro extended release of venlafaxine hydrochloride. Eur. Chem. Bull. 3 (2014), 672–681.
40. Jaurand, M.-C., Fleury, J., Monchaux, G., Nebut, M., Bignon, J., Pleural carcinogenic potency of mineral fibres (asbestos, attapulgite) and their cytotoxicity on cultured cells. J. Natl. Cancer Inst. 79 (1987), 797–804.
41. Joekes, A.M., Rose, G.A., Sutor, J., Multiple renal silica calculi. Br. Med. J. 1 (1973), 146–147.
42. Joshi, G.V., Kevadiya, B.D., Bajaj, H.C., Design and evaluation of controlled drug delivery system of buspirone using inorganic layered clay mineral. Microporous Mesoporous Mater. 132 (2010), 526–530.
43. Jung, H., Kim, H.M., Choy, Y.B., Hwang, S.J., Choy, J.H., Itraconazole-laponite: kinetics and mechanism of drug release. Appl. Clay Sci. 40:1–4 (2008), 99–107.
44. Kaur, M., Datta, M., Synthesis and characterization of biodegradable clay–polymer nanocomposites for oral sustained release of anti-inflammatory drug. Eur. Chem. Bull. 2 (2013), 670–678.
45. Kaur, M., Datta, M., Diclofenac sodium adsorption onto montmorillonite: adsorption equilibrium studies and drug release kinetics. Adsorpt. Sci. Technol. 32 (2014), 365–387.
46. Kevadiya, B.D., Joshi, G.V., Bajaj, H.C., Layered bionanocomposites as carrier for procainamide. Int. J. Pharm. 388 (2010), 280–286.
47. Kevadiya, B.D., Joshi, G.V., Mody, H.M., Bajaj, H.C., Biopolymer–clay hydrogel composites as drug carrier: host–guest intercalation and in vitro release study of lidocaine hydrochloride. Appl. Clay Sci. 52 (2011), 364–367.
48. Kevadiya, B.D., Patel, T.A., Jhala, D.D., Thumbar, R.P., Brahmbhatt, H., Pandya, M.P., Rajkumar, S., Jena, P.K., Joshi, G.V., Gadhia, P.K., Tripathi, C.B., Bajaj, H.C., Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU). Eur. J. Pharm. Biopharm. 81 (2012), 91–101.
49. Kevadiya, B.D., Thumbar, R.P., Rajput, M.M., Rajkumar, S., Brambhatt, H., Joshi, G.V., Dangi, G.P., Mody, H.M., Gadhia, P.K., Bajaj, H.C., Montmorillonite/poly-(epsilon-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property. Eur. J. Pharm. Sci. 47 (2012), 265–272.
50. Kim, J.Y., Yang, J.H., Lee, J.H., Choi, G., Jo, M.R., Choi, S.J., Choy, J.H., 2D inorganic-antimalaria drug–polymer hybrid with pH-responsive solubility. Chem. Asian. J. 10 (2015), 2264–2271.
51. Kong, Y., Ge, H., Xiong, J., Zuo, S., Wei, Y., Yao, C., Deng, L., Palygorskite polypyrrole nanocomposite: A new platform for electrically tunable drug delivery. Appl. Clay Sci. 99 (2014), 119–124.
52. Koshi, K., Kohyama, N., Myojo, T., Fukuda, K., Cell toxicity, haemolytic action and clastogenic activity of asbestos and its substitutes. Ind. Health 29 (1991), 37–56.
53. Lakshmi, M.S., Sriranjani, M., Bakrudeen, H.B., Kannan, A.S., Mandal, A.B., Reddy, B.S.R., Carvedilol/montmorillonite: processing, characterization and release studies. Appl. Clay Sci. 48 (2010), 589–593.
54. Lee, J.H., Choi, G., Oh, Y.J., Park, J.W., Choy, Y.B., Park, M.C., Yoon, Y.J., Lee, H.J., Chang, H.C., Choy, J.H., A nanohybrid system for taste masking of sildenafil. Int. J. Nanomedicine 7 (2012), 1635–1649.
55. Lee, W.F., Chen, Y.C., Effect of bentonite on the physical properties and drug-release behavior of poly(AA-co-PEGMEA)bentonite nanocomposite hydrogels for mucoadhesive. J. Appl. Polym. Sci. 91 (2004), 2934–2941.
56. 2. Gastroenterol. Clin. Biol. 8 (1994), 609–616.
57. Levison, D.A., Crocker, P.R., Banim, S., Wallace, D.M.A., Silica stones in the urinary bladder. Lancet 27 (1982), 704–705.
58. Lin, F.H., Lee, Y.H., Jian, C.H., Wong, J.M., Shieha, M.J., Wang, C.Y., A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23 (2002), 1981–1987.
59. Liu, Y., Lu, X., Wu, F., Deng, N., Adsorption and photooxidation of pharmaceuticals and personal care products on clay minerals. React. Kinet. Mech. Catal. 104 (2011), 61–73.
60. López-Galindo, A., Viseras, C., Cerezo, P., Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl. Clay Sci. 36 (2007), 51–63.
61. López-Galindo, A., Viseras, C., Aguzzi, C., Cerezo, P., Pharmaceutical and cosmetic uses of fibrous clays. Galan, E., Singer, A., (eds.) Developments in Palygorskite-Sepiolite Research A New Outlook on these Nanomaterials, 2011, Elsevier, Amsterdam, 299–324.
62. Marques, I.J., Vaz, P.D., Fernandes, A.C., Nunes, C.D., Advantageous delivery of nifedipine from inorganic materials showing increased solubility and biocompatibility. Microporous Mesoporous Mater. 183 (2014), 192–200.
63. Massaro, M., Colletti, C.G., Noto, R., Riela, S., Poma, P., Guernelli, S., Parisi, F., Milioto, S., Lazzara, G., Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems. Int. J. Pharm. 478 (2015), 476–485.
64. Matlaga, B.R., Shah, O.D., Assimos, D.G., Drug-induced urinary calculi. Rev. Uro. 5:4 (2003), 227–231.
65. McGinity, J.W., Harris, M.R., Increasing dissolution rates of poorly soluble drugs by adsorption to montmorillonite. Drug Develop. Ind. Pharm. 6:1 (1980), 35–48.
66. McGinity, J.W., Lach, J.L., Sustained-release applications of montmorillonite interaction with amphetamine sulfate. J. Pharm. Sci 66:1 (1977), 63–66.
67. Meng, N., Zhou, N.L., Zhang, S.Q., Shen, J., Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite. Int. J. Pharm. 382 (2009), 45–49.
68. Nunes, C.D., Vaz, P.D., Fernandes, A.C., Ferreira, P., Romao, C.C., Calhorda, M.J., Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur. J. Pharm. Biopharm. 66 (2007), 357–365.
69. Oh, J.M., Park, D.H., Choy, J.H., Integrated bio-inorganic hybrid systems for nano-forensics. Chem. Soc. Rev. 40 (2011), 583–595.
70. Oh, Y.J., Choi, G., Choy, Y.B., Park, J.W., Park, J.H., Lee, H.J., Yoon, Y.J., Chang, H.C., Choy, J.H., Aripiprazole-montmorillonite: a new organic–inorganic nanohybrid material for biomedical applications. Chem. Eur. J. 19 (2013), 4869–4875.
71. Ouellet-Plamondon, C., Aranda, P., Favier, A., Habert, G., van Damme, H., Ruiz-Hitzky, E., The Maya blue nanostructured material concept applied to colouring geopolymers. RSC Adv. 5 (2015), 98834–98841.
72. Park, D.H., Yang, J.H., Vinu, A., Elzatahry, A., Choy, J.H., X-ray diffraction and X-ray absorption spectroscopic analyses for intercalative nanohybrids with low crystallinity. Arab. J. Chem., 2015, 10.1016/j.arabjc.2015.07.007.
73. Park, D.H., Hwang, S.J., Oh, J.M., Yang, J.H., Choy, J.H., Polymer–inorganic supramolecular nanohybrids for red, white, green, and blue applications. Prog. Polym. Sci. 38 (2013), 1442–1486.
74. Park, J.K., Choy, Y.B., Oh, J.-M., Kim, J.Y., Hwang, S.J., Choy, J.H., Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 359 (2008), 198–204.
75. Patel, H.A., Shah, S., Shah, D.O., Joshi, P.A., Sustained release of venlafaxine from venlafaxine–montmorillonite–polyvinylpyrrolidone composites. Appl. Clay Sci. 51 (2011), 126–130.
76. Perderiset, M., Saint Etienne, L., Bignon, J., Jaurand, M.C., Interactions of attapulgite (fibrous clay) with human red blood cells. Toxicol. Lett. 47 (1989), 303–309.
77. Pott, F., Bellmann, B., Muhle, H., Rodelsperger, K., Rippe, R.M., Roller, M., Rosenbruch, M., Intraperitoneal injection studies for the evaluation of the carcinogenicity of fibrous phyllosilicates. Bignol, J., (eds.) Health Related Effects of Phyllosilicates NATO ASI Series, G 21, 1990, Springer, Berlin, 319–329.
78. Rayner, J.H., Brown, G., The crystal structure of talc. Clay Clay Miner. 21 (1973), 103–114.
79. Rodrigues, L.A., Figueiras, A., Veiga, F., de Freitas, R.M., Nunes, L.C., da Silva Filho, E.C., da Silva Leite, C.M., The systems containing clays and clay minerals from modified drug release: a review. Colloids Surf. B: Biointerfaces 103 (2013), 642–651.
80. Saha, K., Butola, B.S., Joshi, M., Drug-loaded polyurethane/Clay Nanocomposite Nanofibers for topical drug-delivery application. J. Appl. Polym. Sci., 131, 2013, 40230.
81. Saha, K., Butola, B.S., Joshi, M., Synthesis and characterization of chlorhexidine acetate drug–montmorillonite intercalates for antibacterial applications. Appl. Clay Sci. 101 (2014), 477–483.
82. Saha, K., Butola, B.S., Joshi, M., Drug release behavior of polyurethane/clay nanocomposite: Film vs. nanofibrous web. J. Appl. Polym. Sci., 131, 2014, 40824.
83. Salahuddin, N., Kenawy, E.-R., Abdeen, R., Polyoxypropylene-montmorillonite nanocomposites for drug-delivery vehicles: preparation and characterization. J. Appl. Polym. Sci. 125 (2012), E157–E166.
84. Salcedo, I., Sandri, G., Aguzzi, C., Sandri, G., Bonferoni, M.C., Mori, M., Cerezo, P., Sánchez, R., Viseras, C., Caramella, C., In vitro biocompatibility and mucoadhesion of montmorillonite chitosan nanocomposite: a new drug delivery. Appl. Clay Sci. 55 (2012), 131–137.
85. Salcedo, I., Sandri, G., Aguzzi, C., Bonferoni, C., Cerezo, P., Sanchez-Espejo, R., Viseras, C., Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites. Colloids Surf. B: Biointerfaces 117 (2014), 441–448.
86. Sanchez, C.M., Sanchez, M.J., Vicente, M.T., Dominguez-Gil, A., IR and x-ray diffraction study of chlorpheniramine maleate-montmorillonite interaction. J. Pharm. Sci. 69 (1980), 1142–1144.
87. Sanchez-Martin, M.J., Sanchez-Camazano, M., Sayalero, M.L., Dominguez-Gil, A., Physicochemical study of the interaction of montmorillonite with hydralazine hydrochloride, a cardiovascular drug. Appl. Clay Sci. 3 (1988), 53–61.
88. Seema, Datta, M., Clay–polymer nanocomposites as a novel drug carrier: synthesis, characterization and controlled release study of propranolol hydrochloride. Appl. Clay Sci. 80-81 (2013), 85–92.
89. Seema, Datta, M., In vitro sustained delivery of atenolol, an antihypertensive drug using naturally occurring clay mineral montmorillonite as a carrier. Eur. Chem. Bull. 2 (2013), 942–951.
90. Seema, Datta, M., Organoclay pluronic f68 – montmorillonite, as a sustained release drug release drug delivery vehicle for propranolol hydrochloride. Eur. Chem. Bull. 3 (2014), 593–604.
91. Takahashi, T., Yamada, Y., Kataoka, K., Nagasaki, Y., Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles. J. Control. Release 107 (2005), 408–416.
92. Takahashi, T., Yamaguchi, M., Host-guest interaction between swelling clay minerals and poorly water-soluble drugs. 1. complex formation between a swelling clay mineral and griseofulvin. J. Incl. Phenom. Mol. Recognit. Chem. 10 (1991), 283–297.
93. Vergaro, V., Lvov, Y.M., Leporatti, S., Halloysite clay nanotubes for resveratrol delivery to cancer cells. Macromol. Biosci. 12 (2012), 1265–1271.
94. Viseras, C., Cerezo, P., Sanchez, R., Salcedo, I., Aguzzi, C., Current challenges in clay minerals for drug delivery. Appl. Clay Sci. 48 (2010), 291–295.
95. Viseras, C., Lopez-Galindo, A., Pharmaceutical applications of some Spanish clays (sepiolite, palygorskite, bentonite)_some preformulation studies. Appl. Clay Sci. 14 (1999), 69–82.
96. Wagner, J.C., Griffiths, D.M., Munday, D.E., Experimental studies with palygorskite dusts. Br. J. Ind. Med. 44 (1987), 749–763.
97. Wang, L., Guo, W., Ahao, Y., Preparation and characterization of cefradine/montmorillonite composites. Adv. Mater. Res. 560-561 (2012), 434–437.
98. Wang, Q., O'Hare, D., Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets. Chem. Rev. 112 (2012), 4124–4155.
99. Wang, X., Du, Y., Luo, J., Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology, 19, 2008, 065707.
100. Wei, W., Abdullayev, E., Hollister, A., Mills, D., Lvov, Y.M., Clay Nanotube/Poly(methyl methacrylate) Bone Cement Composites with Sustained Antibiotic Release Macromol. Mater. Eng. 297 (2012), 645–653.
101. Wei, W., Minullina, R., Abdullayev, E., Fakhrullin, R., Mills, D., Lvov, Y., Enhanced efficiency of antiseptics with sustained release from clay nanotubes. RSC Adv. 4:1 (2014), 488–494.
102. Wilson, M.J., A Handbook of Determinative Methods in Clay Mineralogy. 1987, Chapman and Hall, New York.
103. Wu, Y., Zhou, N., Li, W., Gu, H., Fan, Y., Yuan, J., Long-term and controlled release of chlorhexidine-copper(II) from organically modified montmorillonite (OMMT) nanocomposites. Mater. Sci. Eng. C: Mater. Biol. Appl. 33 (2013), 752–757.
104. Xu, D.F., Du, L.H., Mai, W.J., Cai, X., Jiang, Z.Y., Tan, S.Z., Continuous release and antibacterial activity of chlorhexidine acetate intercalated vermiculite. Mater. Res. Innov. 17:3 (2013), 195–200.
105. Yang, J.H., Han, Y.S., Park, M., Park, T., Hwang, S.J., Choy, J.H., New inorganic-based drug delivery system of indoe-3-acetic acid-layered metal hydroxide nanohybrids with controlled release rate. Chem. Mater. 19 (2007), 2679–2685.
106. Yang, J.H., Jung, H., Kim, S.Y., Yo, C.H., Choy, J.H., Heterostructured layered aluminosilicate-itraconazole nanohybrid for drug delivery system. J. Nanosci. Nanotechnol. 13:11 (2013), 7331–7336.
107. Yang, L., Choi, S.K., Shin, H.J., Han, H.K., 3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen. Int. J. Nanomedicine 8 (2013), 4147–4155.
108. Yang, L., Shao, Y., Han, H.K., Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex. Int. J. Pharm. 471 (2014), 258–263.
109. Young, R.A., Hewat, A.W., Verification of the triclinic Crystal Structure of kaolinite. Clay Clay Miner. 1988:36 (1988), 225–232.
110. Yu, W.H., Li, N., Tong, D.S., Zhou, C.H., Lin, C.X., Xu, C.Y., Adsorption of proteins and nucleic acids on clay minerals and their interactions: A review. Appl. Clay Sci. 80-81 (2013), 443–452.